0000927066-17-000003.txt : 20170615
0000927066-17-000003.hdr.sgml : 20170615
20170615175950
ACCESSION NUMBER: 0000927066-17-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170613
FILED AS OF DATE: 20170615
DATE AS OF CHANGE: 20170615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JIGANTI JEANINE MARIE
CENTRAL INDEX KEY: 0001566865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 17914414
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
4
1
wf-form4_149756397456297.xml
FORM 4
X0306
4
2017-06-13
0
0000927066
DAVITA INC.
DVA
0001566865
JIGANTI JEANINE MARIE
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
0
1
0
0
Chief Compliance Officer
Common Stock
2017-06-13
4
M
0
7500
53.16
A
11014
D
Common Stock
2017-06-13
4
M
0
5200
58.94
A
16214
D
Common Stock
2017-06-13
4
F
0
10814
65.22
D
5400
D
Common Stock
2017-06-13
4
S
0
1886
65.5698
D
3514
D
Stock Appreciation Rights
53.16
2017-06-13
4
M
0
7500
53.16
D
2015-12-05
2017-12-05
Common Stock
7500.0
0
D
Stock Appreciation Rights
58.94
2017-06-13
4
M
0
5200
58.94
D
2016-03-19
2019-03-19
Common Stock
5200.0
0
D
Represents the weighted average sale price of $65.5698. The range of prices for the sale of these shares was $65.5500-$65.5900, rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The Stock Appreciation Rights were granted on 12/05/2012. 50% vested on 12/05/2015 and the remaining 50% vested on 12/05/2016.
The Stock Appreciation Rights were granted on 3/19/2013. 50% vested on 3/19/2016 and the remaining 50% vested on 3/19/2017.
/s/ Arturo Sida, Attorney-in-Fact
2017-06-14